BamSEC and AlphaSense Join Forces
Learn More
You must log in to view this page.

Landos Biopharma Inc – Material Contracts

Formerly NASDAQ: LABP
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 11 pages Voting Agreement
12/34/56
EX-10.1
from 10-Q 20 pages Severance Agreement 1
12/34/56
EX-10
from 10-K 7 pages Certain Confidential Information Contained in This Document, Marked by [***], Has Been Omitted Because It Is Not Material and Would Likely Cause Competitive Harm to the Company if Publicly Disclosed First Amendment to License and Collaboration Agreement
12/34/56
EX-10
from 10-K 21 pages Severance Agreement 1
12/34/56
EX-10
from 10-K 3 pages Dear Patrick, I Am Pleased to Confirm the Offer of Employment to You With Landos Biopharma (“Landos”) in the Full-Time Position of Vice President, Controller. You Are Tentatively Scheduled for a Start Date of May 3rd, 2022. Base Salary the Initial Annualized Base Salary for This Position Will Be $300,000.00 Which on a Semi-Monthly Basis Will Be
12/34/56
EX-10
from 10-K 4 pages July 26, 2022 Position
12/34/56
EX-10.1
from 8-K 8 pages Amendment No. 1 to the Amended and Restated Investor’s Rights Agreement
12/34/56
EX-10.1
from 8-K 34 pages Securities Purchase Agreement
12/34/56
EX-10.2
from 10-Q 22 pages Executive Employment Agreement
12/34/56
EX-10.1
from 10-Q 9 pages Revised May 4, 2022 Jyoti Chauhan 42562 Magellan Square Brambleton, Va 20148 Re: Separation Agreement 1. Separation. Your Last Day of Work With the Company and Your Employment Separation Date Will Be May 6, 2022 (The “Separation Date”). 2
12/34/56
EX-10.9
from 10-K Pdf Courtesy Copy
12/34/56
EX-10.9
from 10-K 4 pages Employment Agreement
12/34/56
EX-10.8
from 10-K Pdf Courtesy Copy
12/34/56
EX-10.8
from 10-K 4 pages Employment Agreement
12/34/56
EX-10.7
from 10-K Pdf Courtesy Copy
12/34/56
EX-10.7
from 10-K 6 pages Separation and Release of Claims Agreement
12/34/56
EX-10.6
from 10-K 2 pages Landos Biopharma, Inc. Non-Employee Director Compensation Policy Approved by the Board of Directors on March 30, 2021
12/34/56
EX-10.5
from S-1/A 12 pages Landos Biopharma, Inc. 2021 Employee Stock Purchase Plan Adopted by the Board of Directors: [ ], 2021 Approved by the Stockholders: [ ], 2021
12/34/56
EX-10.3
from S-1/A 14 pages Landos Biopharma, Inc. Indemnification Agreement
12/34/56
EX-10.2
from S-1/A 35 pages Landos Biopharma, Inc. 2019 Equity Incentive Plan
12/34/56